LGALS3 and Myocardial fibrosis: Histological analyses further revealed reduced interstitial fibrosis and lower expression of fibrotic markers, including COL-1, COL-3, Galectin-3 and α-SMA, indicating that β-SITO mitigates myocardial fibrosis.